Vaccinated 80-year-olds show 88% fewer shingles cases (202 vs 1,705 per 100k) compared to unvaccinated peers, with lower but still significant 54% protection at age 65. Shingles affects 1 in 50 people over 80 annually in Spain, causing chronic pain in 15% of cases; over 75,000 Spaniards suffer yearly with incidence rising due to aging population.
EL PAÍS
· Jun 08, 2026
· health
· 5 min de leitura
High
Apuração: Verificado
New shingles vaccine cuts cases by 90% in people over 80, Spain data shows
Shingles causes intense pain that chronifies in up to 15% of patients, significantly impacting quality of life in elderly populations.
◉
Health & Medicine
2812 artigos relacionados
FDA approves Wegovy for heart disease prevention, expanding blockbuste…
infobae · 99% correspondência
El ARN mensajero abre camino a vacunas contra 30 enfermedades infeccio…
infobae · 90% correspondência
Weight-Loss Drugs Show Promise in Reducing Alcohol Cravings, But Clini…
infobae · 90% correspondência
WHO endorses GLP-1 weight-loss drugs, issues first clinical guidance a…
El Tiempo · 90% correspondência
Ozempic: Riesgos crecientes por uso estético sin supervisión médica
Medio digital El Zorro Nortino · 90% correspondência
Cobertura Relacionada
El Mostrador · Aug 23
Guía de alimentos a limitar para proteger la salud cardiovascular
Expertos recomiendan limitar embutidos, bebidas azucaradas y ultraprocesados para reducir riesgos cardiovasculares. La a…
OkDiario · Aug 23 La boca seca no es una molestia menor: cuándo consultar al médicoLa xerostomía o boca seca es un problema infradiagnosticado que afecta a una de cada tres personas mayores de 60 años, f…
Segre.com · Aug 23 Programa pionero de ejercicio monitorizado mejora la salud cardiopulmonar en LleidaUn programa pionero en Lleida utiliza ejercicio físico monitorizado y análisis de 30 variables metabólicas para mejorar …
El País · Aug 23 No habrá una vacuna contra el cáncer, sino una distinta para cada paciente y tumorModerna y MSD avanzan hacia la aprobación de una vacuna de ARN mensajero personalizada contra el melanoma que reduce un …
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Spain's new shingles vaccine demonstrates 90% effectiveness in elderly populations, representing a significant public health achievement with minimal geopolitical implications.
Escalation Risk
low
Confidence
HIGH
Spain
European Union
Strengthens GSK's market position in European healthcare; enhances Spain's public health credibility; demonstrates EU capacity for coordinated vaccine deployment across member states.
Lente Econômica
📈
Spain's publicly-funded shingles vaccine demonstrates 90% effectiveness in preventing disease among those over 80, with significant public health and economic benefits offsetting initial supply and cost challenges.
Market Signal
bullish
Confidence
HIGH
Pharmaceutical/Biotechnology
Healthcare/Public Health
Medical Devices & Diagnostics
Elderly Care Services
Insurance/Healthcare Administration
Elderly citizens (65+) benefit from reduced disease incidence, lower chronic pain complications, and improved quality of life. Reduced healthcare utilization for shingles treatment and post-herpetic neuralgia management lowers out-of-pocket costs for seniors and reduces burden on family caregivers.
Successful real-world outcomes strengthen justification for continued public vaccine funding despite €240 per-patient cost. May accelerate similar vaccine programs across EU healthcare systems. Demonstrates return on investment for preventive healthcare spending, potentially influencing budget allocation toward geriatric prevention programs. Could prompt regulatory harmonization of vaccine procurement across autonomous communities.